Daejeon, South Korea

Yang Seon Kim

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ensoltek Co., Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yang Seon Kim. Retrieved from https://idiyas.com/inventor/yang-seon-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yang Seon Kim: Innovator in Peptide Technology

Introduction

Yang Seon Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of peptide technology, particularly in the treatment of various medical conditions. His innovative work has the potential to impact the healthcare industry positively.

Latest Patents

Yang Seon Kim holds a patent for a peptide that comprises an amino acid sequence of SEQ ID NO: 1. This invention is effective for treating degenerative disc diseases, body organ fibrosis, cancer, and glomerulosclerosis. Additionally, it plays a role in inhibiting TGF-beta 1 signaling, showcasing its therapeutic potential.

Career Highlights

Yang Seon Kim is associated with Ensoltek Co., Ltd., where he continues to develop and refine his innovative ideas. His work in peptide technology has positioned him as a key figure in the research and development of new treatments.

Collaborations

He collaborates with talented individuals such as Hae Jin Kim and Eun Joung Moon, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Yang Seon Kim's contributions to peptide technology highlight his role as an influential inventor in the medical field. His work promises to advance treatment options for various diseases, making a significant impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…